
Dian Cook Jacobson
Examiner (ID: 16940)
| Most Active Art Unit | 1814 |
| Art Unit(s) | 1814, 1805, 1653, 1801, 1652 |
| Total Applications | 363 |
| Issued Applications | 210 |
| Pending Applications | 19 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3772644
[patent_doc_number] => 05807839
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Method for stimulating red blood cell production'
[patent_app_type] => 1
[patent_app_number] => 8/835797
[patent_app_country] => US
[patent_app_date] => 1997-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2343
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/807/05807839.pdf
[firstpage_image] =>[orig_patent_app_number] => 835797
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/835797 | Method for stimulating red blood cell production | Apr 14, 1997 | Issued |
Array
(
[id] => 3943000
[patent_doc_number] => 05981704
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Kainate-binding, human CNS receptors of the EAA2 family'
[patent_app_type] => 1
[patent_app_number] => 8/822238
[patent_app_country] => US
[patent_app_date] => 1997-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 9
[patent_no_of_words] => 14001
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981704.pdf
[firstpage_image] =>[orig_patent_app_number] => 822238
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/822238 | Kainate-binding, human CNS receptors of the EAA2 family | Mar 19, 1997 | Issued |
Array
(
[id] => 4022638
[patent_doc_number] => 05882887
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-16
[patent_title] => 'Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin'
[patent_app_type] => 1
[patent_app_number] => 8/793294
[patent_app_country] => US
[patent_app_date] => 1997-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6557
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/882/05882887.pdf
[firstpage_image] =>[orig_patent_app_number] => 793294
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/793294 | Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin | Mar 10, 1997 | Issued |
Array
(
[id] => 4022582
[patent_doc_number] => 05882883
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-16
[patent_title] => 'Process for the production of secondary metabolites'
[patent_app_type] => 1
[patent_app_number] => 8/793786
[patent_app_country] => US
[patent_app_date] => 1997-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9382
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/882/05882883.pdf
[firstpage_image] =>[orig_patent_app_number] => 793786
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/793786 | Process for the production of secondary metabolites | Mar 4, 1997 | Issued |
Array
(
[id] => 3937326
[patent_doc_number] => 05976530
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Peptide plasminogen activators'
[patent_app_type] => 1
[patent_app_number] => 8/799823
[patent_app_country] => US
[patent_app_date] => 1997-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6384
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976530.pdf
[firstpage_image] =>[orig_patent_app_number] => 799823
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/799823 | Peptide plasminogen activators | Feb 12, 1997 | Issued |
| 08/797907 | METHODS OF INDENTIFYING AGENTS FOR USE IN TREATING LENTIVIRAL INFECTION | Feb 9, 1997 | Abandoned |
Array
(
[id] => 4002560
[patent_doc_number] => 05858970
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Polypeptide having Factor Xa inhibitory activity'
[patent_app_type] => 1
[patent_app_number] => 8/779379
[patent_app_country] => US
[patent_app_date] => 1997-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 21233
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858970.pdf
[firstpage_image] =>[orig_patent_app_number] => 779379
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/779379 | Polypeptide having Factor Xa inhibitory activity | Jan 6, 1997 | Issued |
Array
(
[id] => 3799754
[patent_doc_number] => 05830461
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Methods for promoting wound healing and treating transplant-associated vasculopathy'
[patent_app_type] => 1
[patent_app_number] => 8/745375
[patent_app_country] => US
[patent_app_date] => 1996-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 16613
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830461.pdf
[firstpage_image] =>[orig_patent_app_number] => 745375
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/745375 | Methods for promoting wound healing and treating transplant-associated vasculopathy | Nov 7, 1996 | Issued |
Array
(
[id] => 4152036
[patent_doc_number] => 06107072
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-22
[patent_title] => 'Thermostable geranylgeranyl diphosphate synthase'
[patent_app_type] => 1
[patent_app_number] => 8/733837
[patent_app_country] => US
[patent_app_date] => 1996-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5752
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/107/06107072.pdf
[firstpage_image] =>[orig_patent_app_number] => 733837
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/733837 | Thermostable geranylgeranyl diphosphate synthase | Oct 17, 1996 | Issued |
| 08/725251 | HUMAN BIKUNIN | Oct 3, 1996 | Abandoned |
Array
(
[id] => 3995556
[patent_doc_number] => 05922586
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'DNA constructs and methods of producing cellulytic enzymes'
[patent_app_type] => 1
[patent_app_number] => 8/713298
[patent_app_country] => US
[patent_app_date] => 1996-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9728
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922586.pdf
[firstpage_image] =>[orig_patent_app_number] => 713298
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/713298 | DNA constructs and methods of producing cellulytic enzymes | Sep 12, 1996 | Issued |
Array
(
[id] => 3999003
[patent_doc_number] => 05858727
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Secretion of outer membrane proteins of gram-negative bacteria by means of gram-positive host organisms'
[patent_app_type] => 1
[patent_app_number] => 8/676378
[patent_app_country] => US
[patent_app_date] => 1996-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3241
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858727.pdf
[firstpage_image] =>[orig_patent_app_number] => 676378
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/676378 | Secretion of outer membrane proteins of gram-negative bacteria by means of gram-positive host organisms | Jul 17, 1996 | Issued |
Array
(
[id] => 4040791
[patent_doc_number] => 05874239
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Biotinylation of proteins'
[patent_app_type] => 1
[patent_app_number] => 8/586772
[patent_app_country] => US
[patent_app_date] => 1996-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15182
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874239.pdf
[firstpage_image] =>[orig_patent_app_number] => 586772
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/586772 | Biotinylation of proteins | Jul 14, 1996 | Issued |
Array
(
[id] => 3981612
[patent_doc_number] => 05948889
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-07
[patent_title] => 'Compositions and methods for screening antimicrobials'
[patent_app_type] => 1
[patent_app_number] => 8/651818
[patent_app_country] => US
[patent_app_date] => 1996-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16039
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/948/05948889.pdf
[firstpage_image] =>[orig_patent_app_number] => 651818
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/651818 | Compositions and methods for screening antimicrobials | May 20, 1996 | Issued |
Array
(
[id] => 3923999
[patent_doc_number] => 05952198
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-14
[patent_title] => 'Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition'
[patent_app_type] => 1
[patent_app_number] => 8/634001
[patent_app_country] => US
[patent_app_date] => 1996-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1951
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/952/05952198.pdf
[firstpage_image] =>[orig_patent_app_number] => 634001
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/634001 | Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition | Apr 16, 1996 | Issued |
Array
(
[id] => 4033084
[patent_doc_number] => 05856126
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Peptide having anti-thrombus activity and method of producing the same'
[patent_app_type] => 1
[patent_app_number] => 8/612840
[patent_app_country] => US
[patent_app_date] => 1996-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 30
[patent_no_of_words] => 18808
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856126.pdf
[firstpage_image] =>[orig_patent_app_number] => 612840
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/612840 | Peptide having anti-thrombus activity and method of producing the same | Mar 19, 1996 | Issued |
| 08/606271 | METHOD FOR TREATING OPHTHALMIC DISORDERS WITH IGFBP | Feb 22, 1996 | Abandoned |
Array
(
[id] => 3934122
[patent_doc_number] => 05972698
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Tryptase inhibitor'
[patent_app_type] => 1
[patent_app_number] => 8/586676
[patent_app_country] => US
[patent_app_date] => 1996-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17154
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972698.pdf
[firstpage_image] =>[orig_patent_app_number] => 586676
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/586676 | Tryptase inhibitor | Jan 24, 1996 | Issued |
Array
(
[id] => 4021343
[patent_doc_number] => 05925535
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-20
[patent_title] => 'Transketolase'
[patent_app_type] => 1
[patent_app_number] => 8/590454
[patent_app_country] => US
[patent_app_date] => 1996-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 6861
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/925/05925535.pdf
[firstpage_image] =>[orig_patent_app_number] => 590454
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/590454 | Transketolase | Jan 22, 1996 | Issued |
Array
(
[id] => 4062305
[patent_doc_number] => 05866425
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Calibrator for prothrombin time (PT) assays'
[patent_app_type] => 1
[patent_app_number] => 8/587170
[patent_app_country] => US
[patent_app_date] => 1996-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11486
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866425.pdf
[firstpage_image] =>[orig_patent_app_number] => 587170
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/587170 | Calibrator for prothrombin time (PT) assays | Jan 15, 1996 | Issued |